4 Sommaire Préface........................................................................................................................................................................................................................................................ 7 Introduction.........................................................................................................................................................................................................................................9 Fiches des médicaments 13 Abémaciclib, Verzenios®................................................................................................................................................................................................ 14 Abiratérone acétate, Zytiga®..................................................................................................................................................................................... 18 Anastrozole, Arimidex®......................................................................................................................................................................................................21 Apalutamide, Erleada®.......................................................................................................................................................................................................24 Capécitabine, Xeloda®. .....................................................................................................................................................................................................28 Protocole Carbo-Taxol + Pembrolizumab. .........................................................................................................................................32 Darolutamide, Nubeqa®..................................................................................................................................................................................................36 Docétaxel, Taxotère®...........................................................................................................................................................................................................39 Durvalumab, Imfinzi®..........................................................................................................................................................................................................43 Protocole EC : Épirubicine + Cyclophosphamide................................................................................................................... 46 Enzalutamide, Xtandi®.......................................................................................................................................................................................................50 Exémestane, Aromasine®..............................................................................................................................................................................................54 Protocole Folfiri : Acide folinique + 5-fluorouracile + irinotécan...................................................................... 57 Protocole Folfirinox : Acide folinique + 5-fluorouracile + oxaliplatine + irinotécan............. 60 Protocole Folfox : 5-fluorouracile + oxaliplatine + leucovorine. ....................................................................... 64 Hormonothérapie anti-androgénique Cyprotérone, Androcur® ; bicalutamide, Casodex® ; Dégarélix, Firmagon® ; goséréline, Zoladex® ; leuproréline, Enantone® ; triptoréline, Decapeptyl®............................................................................ 68 Ibrutinib, Imbruvica®.............................................................................................................................................................................................................71 Ipilimumab, Yervoy®.............................................................................................................................................................................................................76 Létrozole, Femara®................................................................................................................................................................................................................ 81 Niraparib, Zejula®..................................................................................................................................................................................................................... 84 Nivolumab, Opdivo®........................................................................................................................................................................................................... 88 Olaparib, Lynparza®..............................................................................................................................................................................................................94 Paclitaxel, Taxol®...................................................................................................................................................................................................................... 98 Palbociclib, Ibrance®....................................................................................................................................................................................................... 103 Pembrolizumab, Keytruda®................................................................................................................................................................................... 106 Pertuzumab, Perjeta®..................................................................................................................................................................................................... 112 Ribociclib, Kisqali®.................................................................................................................................................................................................................117 Rucaparib, Rubraca®......................................................................................................................................................................................................... 121 Sacituzumab govitecan, Trodelvy®..............................................................................................................................................................124
RkJQdWJsaXNoZXIy NjA3NzQ=